Meeder Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33	Closed	-$1K	–	1759
2022 Q3	$1K	Hold	33	–	–	﹤0.01%	2011
2022 Q2	$1K	Sell	33 -9	-21%	-$302	﹤0.01%	2070
2022 Q1	$1K	Buy	+42	New	+$1.58K	﹤0.01%	2239
2021 Q4	–	Sell	-7,995	Closed	-$354K	–	2115
2021 Q3	$354K	Buy	7,995 +6,695	+515%	+$307K	0.02%	568
2021 Q2	$74K	Buy	1,300 +1,215	+1,429%	+$85.9K	﹤0.01%	997
2021 Q1	$6K	Buy	85 +1	+1%	+$82	﹤0.01%	1812
2020 Q4	$7K	Hold	84	–	–	﹤0.01%	1114
2020 Q3	$5K	Buy	84 +5	+6%	+$253	﹤0.01%	1587
2020 Q2	$3K	Sell	79 -17	-18%	-$617	﹤0.01%	1691
2020 Q1	$3K	Buy	96 +24	+33%	+$1.39K	﹤0.01%	1986
2019 Q4	$5K	Sell	72 -29	-29%	-$3.57K	﹤0.01%	1801
2019 Q3	$14K	Sell	101 -1	-1%	-$167	﹤0.01%	1423
2019 Q2	$19K	Buy	102 +66	+183%	+$11.3K	﹤0.01%	1255
2019 Q1	$6K	Buy	+36	New	+$5.21K	﹤0.01%	1370
2018 Q3	–	Sell	-1,896	Closed	-$297K	–	1671
2018 Q2	$297K	Buy	1,896 +1,507	+387%	+$237K	0.03%	446
2018 Q1	$63K	Buy	389 +210	+117%	+$35.7K	0.01%	623
2017 Q4	$29K	Buy	179 +163	+1,019%	+$15.8K	﹤0.01%	826
2017 Q3	$1K	Buy	+16	New	+$1.26K	﹤0.01%	1562